InvestorsHub Logo
Followers 75
Posts 4668
Boards Moderated 0
Alias Born 09/06/2003

Re: bcblbrbm post# 4311

Friday, 06/15/2007 10:59:42 AM

Friday, June 15, 2007 10:59:42 AM

Post# of 12660
Is the FDA licensing process subjective enough for a hostile FDA to fail us on the interim look, even if we pass statistically?

To some degree. For instance if the alpha assigned to the interim is 0.01 and Dendreon announces a p value of 0.0095 then there is reason for concern that the FDA will 'find' an error somewhere. (They might approve anyway - but it is far from certain)

OTOH if they get a p value of 0.001 on the interim vs an alpha of 0.01 then it is unlikely that Provenge would be rejected.

FWIW.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.